Wuhan Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : http://www.wibp.com.cn/
Main Product : Vaccines, biological products
Company Profile
Wuhan Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines and biological products. With a history dating back to 1967, the company has established a strong presence in the domestic market and is expanding its reach in international markets. Known for its high-quality products and commitment to public health, Wuhan Institute of Biological Products Co., Ltd. continues to innovate and grow in the ever-evolving biopharmaceutical industry.
Liaoning Chengda Biotechnology Co., Ltd.
Establishment time : 2002
website : www.lncd.com
Main Product : Probiotics, feed additives, veterinary drugs
Company Profile
Liaoning Chengda Biotechnology Co., Ltd. is a leading biotechnology company in China, specializing in the research, development, and production of probiotics, feed additives, and veterinary drugs. Since its establishment in 2002, the company has grown to become a key player in the market, serving customers in both domestic and international markets. With a focus on innovation and quality, Chengda Biotechnology continues to strive for excellence in the biotechnology industry.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 1998
website : www.tianyuanbio.com
Main Product : Recombinant proteins, monoclonal antibodies, vaccines
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a biopharmaceutical company founded in 1998. It specializes in the production of recombinant proteins, monoclonal antibodies, and vaccines. With a medium-sized company size, Tianyuan Bio-Pharmaceutical has established itself as a leading manufacturer in the industry with a strong presence in markets across China, Asia, Europe, and North America. The company is known for its innovative research and development capabilities, making it a key player in the competitive biopharmaceutical market.
Changchun Institute of Biological Products Co., Ltd.
Establishment time : 1941
website : http://www.changchunbio.com
Main Product : Vaccines, blood products, diagnostic reagents
Company Profile
Changchun Institute of Biological Products Co., Ltd. is a renowned company with a history dating back to 1941. They specialize in the production of vaccines, blood products, and diagnostic reagents. With a large company size and a strong presence in markets such as China, Asia, and Africa, they are a leading manufacturer in the field of biological products. Visit their website for more information: http://www.changchunbio.com.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : http://www.cibp.cicams.ac.cn/
Main Product : Vaccines, biological products
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines and biological products. With a history dating back to 1967, the company has established a strong presence in both the domestic and international markets. With a large company size and a focus on innovation, Chengdu Institute of Biological Products Co., Ltd. continues to be a key player in the biopharmaceutical industry.
Liaoning Yisheng Biopharmaceutical Co., Ltd.
Establishment time : 2006
website : www.yishengbio.com
Main Product : Pharmaceutical products, vaccines, biologics
Company Profile
Liaoning Yisheng Biopharmaceutical Co., Ltd. is a reputable pharmaceutical company founded in 2006. They specialize in producing a wide range of pharmaceutical products, vaccines, and biologics. With a medium-sized company size, they have a strong presence in both the domestic market in China and international markets. Despite facing strong competition in the industry, the company thrives on its commitment to research and development to deliver high-quality products to its customers. Visit their website at www.yishengbio.com for more information.
Shanghai Institute of Biological Products Co., Ltd.
Establishment time : Shanghai Institute of Biological Products Co., Ltd. was founded in 1969 and has since become a key player in the biopharmaceutical industry.
website :
Main Product : With over 1000 employees, the company operates on a large scale to meet the growing demand for healthcare products.
Company Profile
With a strong competitive position in the market, the company continues to expand its product offerings and reach new customers with its cutting-edge biopharmaceutical solutions.
July 19, 2024
